Skip to main content
Tech.euFundingExplorerBeta

Basque Country Venture Capital Fund (Spri)

Investor profile

Venture capital

Basque Country Venture Capital Fund (Spri) has backed 1 European tech company across 1 funding round in 2023, joining rounds totalling €2.0M. Most active in Healthtech. Data as of 4 Nov 2026.

Deals
1
distinct rounds
Companies
1
backed
Active span
2023
1 yr
Total round €
€2.0M
sum of rounds joined

Deals by year

distinct rounds / year
Basque Country Venture Capital Fund (Spri) — deals by year — interactive chart.
Data table
Basque Country Venture Capital Fund (Spri) — deals by year
20231

Top sectors

by deals
Basque Country Venture Capital Fund (Spri) — top sectors — interactive chart.
Data table
Basque Country Venture Capital Fund (Spri) — top sectors
Healthtech1

Stages

by deals
Basque Country Venture Capital Fund (Spri) — stages — interactive chart.
Data table
Basque Country Venture Capital Fund (Spri) — stages
Other1

Countries

by deals
Basque Country Venture Capital Fund (Spri) — countries — interactive chart.
Data table
Basque Country Venture Capital Fund (Spri) — countries
Spain1

Co-investment network

shared rounds
Co-investment network — interactive chart.
Basque Country Venture Capital Fund (Spri) — 1 dealsBasque Country Venture Capital Fund (Spri)American North South Ventures — 1 shared deals · click to openAmerican North South VenturesBexen Medical — 1 shared deals · click to openBexen MedicalCleon Capital — 1 shared deals · click to openCleon CapitalColumbus Venture Partners — 1 shared deals · click to openColumbus Venture PartnersMONDRAGON — 1 shared deals · click to openMONDRAGONSangha Capital — 1 shared deals · click to openSangha CapitalViscofan — 1 shared deals · click to openViscofan

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
Cocoon BioscienceSpain1€2.0M

Biggest deals

top 10 by amount
CompanyStageAmountDate
Cocoon BioscienceOther€2.0M2023-11
← Back to investors